| Application no. and date | 13171373.7 (espacenet) (Federated) (European Patent Register), 20070802 | | Patent/reg. no. and date | DK/EP 2644591, 20171213 | | Publication date | 20131002 | | Priority no. and date | GB 0615620, 20060805 | | EP pub. no. and date |
EP 2644591 20131002 | | Effective date | | | Applicant/owner | Astrazeneca AB, 151 85 Södertälje, SE | | Applicant ref. no. | AST 102446-EP-ETD | | Inventor | MITSUDA, Masaru, Kaneka Corporation
3-2-4, Nakanoshima
Kita-ku, Osaka 530-8288, JP,
MOROSHIMA, Tadashi, Kaneka Corporation
3-2-4, Nakanoshima
Kita-ku, Osaka 530-8288, JP,
TSUKUYA, Kentaro, Kaneka Corporation
3-2-4, Nakanoshima
Kita-ku, Osaka 530-8288, JP,
WATABE, Kazuhiko, Kaneka Corporation
3-2-4, Nakanoshima
Kita-ku, Osaka 530-8288, JP,
YAMADA, Masahiko, Kaneka Corporation
3-2-4, Nakanoshima
Kita-ku, Osaka 530-8288, JP | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07C 233/58 (2006.01) | | Title | OPTISK AKTIVT 2-ARYLCYCLOPROPANCARBOXAMID-MELLEMPRODUKT | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
